Nuveen Asset Management, LLC Genprex, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.11 - $4.87 $1.25 Million - $1.95 Million	-400,932 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.66 - $7.67 $1.11 Million - $2.33 Million	303,236 Added 310.39%	400,932 $1.73 Million
Q4 2020 Feb 16, 2021	BUY	$3.03 - $5.51 $7,050 - $12,821	2,327 Added 2.44%	97,696 $406,000
Q3 2020 Nov 16, 2020	SELL	$2.9 - $4.29 $116,887 - $172,912	-40,306 Reduced 29.71%	95,369 $321,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $3.64 $269,993 - $493,857	135,675 New	135,675 $426,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $64.3M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.